Literature DB >> 21935612

The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells.

YuJie Xing1, AnLin Lv, Li Wang, XueBo Yan.   

Abstract

Bone marrow mesenchymal stem cells (BMMSCs) are ideal seed cells for tissue engineering and regenerative medicine. Many studies have shown that 5-azacytidine (5-aza) can induce BMMSCs to differentiate into cardiomyogenic cells, but some issues still remain to be resolved. In this study, we investigated the effects of angiotensin II (Ang II) on the proliferation and differentiation of BMMSCs induced by 5-aza in vitro. BMMSCs were isolated from the bone marrow of Sprague-Dawley rats by density gradient centrifugation. The third-passage cells were divided into four groups: the Ang II group (0. 1 μmol/l) (group A), the 5-aza group (10 μmol/l) (group B), the Ang II combined with 5-aza group (0.1 and 10 μmol/l) (group C), and the untreated group as control. After 24 h of induction, the medium was changed to the complete culture medium without any inductor, and the cells were cultured for 3 weeks. Morphological changes were observed under a phase contrast microscope. The effect of Ang II and 5-aza on BMMSC proliferation was evaluated by the methyl thiazolyl tetrazolium (MTT) assay. Cardiomyogenic cells were identified through immunofluorescence staining, and the induction ratio was examined by flow cytometry. The level of cardiac troponin I (cTnI) was examined by western blotting, and the ultrastructures of the induced cells were viewed with a transmission electron microscope. The MTT assay showed that the cell proliferation in group C outweighed that in either group A or group B, but no significant difference existed between group A and group B. The expression of specific proteins, namely, cTnI and sarcomeric α-actin in induced BMMSCs was verified as positive. Flow cytometry showed that the induction ratio in group C was higher than that in group A or group B. The protein levels of cTnI in groups A, B, and C were significantly higher than those in the control group. Transmission electron microscopy showed that the induced cells had myofilaments, z line-like substances, desmosomes, and gap junctions. Angiotensin II and 5-azacytidine can promote the proliferation and differentiation of BMMSCs into cardiomyocyte-like cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21935612     DOI: 10.1007/s11010-011-1067-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase.

Authors:  R K Jaiswal; N Jaiswal; S P Bruder; G Mbalaviele; D R Marshak; M F Pittenger
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

2.  Ground-breaking stem-cell work has been reproduced.

Authors:  Angelo L Vescovi; Brent A Reynolds; Rodney L Rietze; Christopher Bjornson
Journal:  Nature       Date:  2007-05-17       Impact factor: 49.962

3.  Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta.

Authors:  G A Stouffer; G K Owens
Journal:  Circ Res       Date:  1992-04       Impact factor: 17.367

4.  Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell.

Authors:  Tingzhong Wang; Zhengyun Xu; Wenhui Jiang; Aiqun Ma
Journal:  Int J Cardiol       Date:  2005-08-24       Impact factor: 4.164

5.  Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.

Authors:  Jan Kajstura; Marcello Rota; Brian Whang; Stefano Cascapera; Toru Hosoda; Claudia Bearzi; Daria Nurzynska; Hideko Kasahara; Elias Zias; Massimiliano Bonafé; Bernardo Nadal-Ginard; Daniele Torella; Angelo Nascimbene; Federico Quaini; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Circ Res       Date:  2004-11-29       Impact factor: 17.367

Review 6.  Angiotensin II and the pathophysiology of cardiovascular remodeling.

Authors:  B Williams
Journal:  Am J Cardiol       Date:  2001-04-19       Impact factor: 2.778

7.  Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes.

Authors:  Meifeng Xu; Maqsood Wani; Yan-Shan Dai; Jiang Wang; Mei Yan; Ahmar Ayub; Muhammad Ashraf
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

8.  Autocrine TGF-beta1 mediates angiotensin II-induced proliferative response of cerebral vessels in vivo.

Authors:  Vladimir V Yurovsky; Volodymyr Gerzanich; Svetlana Ivanova; Yafeng Dong; Orest Tsymbalyuk; J Marc Simard
Journal:  Am J Hypertens       Date:  2007-09       Impact factor: 2.689

9.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

Authors:  Yoshinori Miyahara; Noritoshi Nagaya; Masaharu Kataoka; Bobby Yanagawa; Koichi Tanaka; Hiroyuki Hao; Kozo Ishino; Hideyuki Ishida; Tatsuya Shimizu; Kenji Kangawa; Shunji Sano; Teruo Okano; Soichiro Kitamura; Hidezo Mori
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

View more
  21 in total

1.  Adipose tissue derived mesenchymal stem cells are better respondents to TGFβ1 for in vitro generation of cardiomyocyte-like cells.

Authors:  Anupama Kakkar; Sushmita Bose Nandy; Suchi Gupta; Balram Bharagava; Balram Airan; Sujata Mohanty
Journal:  Mol Cell Biochem       Date:  2019-06-21       Impact factor: 3.396

2.  Freeze-dried rat bone marrow mesenchymal stem cell paracrine factors: a simplified novel material for skin wound therapy.

Authors:  Yan Peng; Min Xuan; Jiping Zou; Hongwei Liu; Ziyuan Zhuo; Yu Wan; Biao Cheng
Journal:  Tissue Eng Part A       Date:  2014-12-11       Impact factor: 3.845

3.  In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells.

Authors:  Peter Szaraz; Yarden S Gratch; Farwah Iqbal; Clifford L Librach
Journal:  J Vis Exp       Date:  2017-08-09       Impact factor: 1.355

4.  Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells.

Authors:  Truc Le-Buu Pham; Tam Thanh Nguyen; Anh Van Bui; My Thu Nguyen; Phuc Van Pham
Journal:  Cytotechnology       Date:  2014-11-07       Impact factor: 2.058

5.  Cardiomyocyte-like cells differentiation from non β-catenin expression mesenchymal stem cells.

Authors:  Qing Gao; Xiantong Hu; Xijuan Jiang; Maojuan Guo; Hong Ji; Yijing Wang; Yingchang Fan
Journal:  Cytotechnology       Date:  2014-04-11       Impact factor: 2.058

6.  Aspirin attenuates angiotensin II-induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF-κB activation.

Authors:  Fenxi Zhang; Ming Lu; Huaibin Wang; Tongming Ren
Journal:  Biomed Rep       Date:  2013-08-23

Review 7.  Bone Marrow Origin of Coronary Artery Diseases: The Impact of the Local Renin-Angiotensin System.

Authors:  Ugur Nadir Karakulak; Elifcan Aladag; Ibrahim Celalettin Haznedaroğlu
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

Review 8.  Cardiac Progenitor Cells.

Authors:  Shaimaa Shouman; Amr Zaher; Alaa Abdelhameed; Sara Elshaboury; Samar Sakr; Bahaa Eldin Fouda; Haya Mohamed; Nagwa El-Badri
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes.

Authors:  Christophe M Raynaud; Najeeb Halabi; David A Elliott; Jennifer Pasquier; Andrew G Elefanty; Edouard G Stanley; Arash Rafii
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

Review 10.  Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy.

Authors:  Han Shen; Ying Wang; Zhiwei Zhang; Junjie Yang; Shijun Hu; Zhenya Shen
Journal:  Stem Cells Int       Date:  2015-08-03       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.